74 related articles for article (PubMed ID: 9673058)
1. [Detection of metastatic activity of the MCF-7 multidrug resistant cell line cultured in spheroids].
Jardillier JC; Affoue M; Bobichon H; Delvincourt C; Madoulet C
Bull Acad Natl Med; 1998; 182(3):651-61; discussion 661-3. PubMed ID: 9673058
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional culture and multidrug resistance: effects on immune reactivity of MCF-7 cells by monocytes.
Mougel L; Tarpin M; Albert P; Le Naour R; Devy J; Kaplan H; Ventéo L; Carlier A; Madoulet C
Anticancer Res; 2004; 24(2B):935-41. PubMed ID: 15161047
[TBL] [Abstract][Full Text] [Related]
3. Implication of necrosis-linked p53 aggregation in acquired apoptotic resistance to 5-FU in MCF-7 multicellular tumour spheroids.
Lee SY; Jeong EK; Jeon HM; Kim CH; Kang HS
Oncol Rep; 2010 Jul; 24(1):73-9. PubMed ID: 20514446
[TBL] [Abstract][Full Text] [Related]
4. The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: analysis of the possible molecular basis.
Poma P; Notarbartolo M; Labbozzetta M; Maurici A; Carina V; Alaimo A; Rizzi M; Simoni D; D'Alessandro N
Int J Mol Med; 2007 Sep; 20(3):329-35. PubMed ID: 17671737
[TBL] [Abstract][Full Text] [Related]
5. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
6. Differential changes in purine nucleotides after Doxorubicin treatment of human cancer cells in vitro.
Walenta S; Feigk B; Wachsmuth I; Dunkern T; Degani H; Mueller-Klieser W
Int J Oncol; 2002 Aug; 21(2):289-96. PubMed ID: 12118323
[TBL] [Abstract][Full Text] [Related]
7. Distinctive alterations of invasiveness, drug resistance and cell-cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant.
dit Faute MA; Laurent L; Ploton D; Poupon MF; Jardillier JC; Bobichon H
Clin Exp Metastasis; 2002; 19(2):161-8. PubMed ID: 11964080
[TBL] [Abstract][Full Text] [Related]
8. Circumvention of tumor multidrug resistance by a new annonaceous acetogenin: atemoyacin-B.
Fu LW; Pan QC; Liang YJ; Huang HB
Zhongguo Yao Li Xue Bao; 1999 May; 20(5):435-9. PubMed ID: 10678092
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restore anticancer drug efficacy.
Walker J; Martin C; Callaghan R
Eur J Cancer; 2004 Mar; 40(4):594-605. PubMed ID: 14962729
[TBL] [Abstract][Full Text] [Related]
10. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
[TBL] [Abstract][Full Text] [Related]
11. Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells.
Ravizza R; Gariboldi MB; Molteni R; Monti E
Oncol Rep; 2008 Sep; 20(3):625-30. PubMed ID: 18695915
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanoma.
Yu Y; Wang ZH; Zhang L; Yao HJ; Zhang Y; Li RJ; Ju RJ; Wang XX; Zhou J; Li N; Lu WL
Biomaterials; 2012 Feb; 33(6):1808-20. PubMed ID: 22136714
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species-linked regulation of the multidrug resistance transporter P-glycoprotein in Nox-1 overexpressing prostate tumor spheroids.
Wartenberg M; Hoffmann E; Schwindt H; Grünheck F; Petros J; Arnold JR; Hescheler J; Sauer H
FEBS Lett; 2005 Aug; 579(20):4541-4549. PubMed ID: 16083877
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
Ogretmen B; McCauley MD; Safa AR
Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
[TBL] [Abstract][Full Text] [Related]
15. Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer.
Labbozzetta M; Notarbartolo M; Poma P; Maurici A; Inguglia L; Marchetti P; Rizzi M; Baruchello R; Simoni D; D'Alessandro N
Ann N Y Acad Sci; 2009 Feb; 1155():278-83. PubMed ID: 19250217
[TBL] [Abstract][Full Text] [Related]
16. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
17. Loss of E-cadherin in multidrug resistant breast cancer cell line MCF-7/Adr: possible implication in the enhanced invasive ability.
Lu L; Zhou D; Jiang X; Song K; Li K; Ding W
Eur Rev Med Pharmacol Sci; 2012 Sep; 16(9):1271-9. PubMed ID: 23047512
[TBL] [Abstract][Full Text] [Related]
18. Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines.
Krishna CM; Kegelaer G; Adt I; Rubin S; Kartha VB; Manfait M; Sockalingum GD
Biopolymers; 2006 Aug; 82(5):462-70. PubMed ID: 16493658
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
Peer D; Dekel Y; Melikhov D; Margalit R
Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283
[TBL] [Abstract][Full Text] [Related]
20. Quantitative distinction of cisplatin-sensitive and -resistant mouse fibrosarcoma cells grown in multicell tumor spheroids.
Frenzel KR; Saller RM; Kummermehr J; Schultz-Hector S
Cancer Res; 1995 Jan; 55(2):386-91. PubMed ID: 7812971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]